Intravenous trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonia

The American Journal of Medicine
F R Sattler, J S Remington

Abstract

Twenty-nine immunocompromised patients were treated with intravenous trimethoprim-sulfamethoxazole for possible Pneumocystis carinii pneumonia. The diagnosis was established in 15 severely hypoxemic patients with lymphoreticular malignancy or cardiac transplants by open lung biopsy or transthoracic needle aspirate. In 13 (87 percent) of the 15, the response to therapy was rapid. They became afebrile in a mean of 2.1 days, showed improved arterial blood oxygenation in 4.7 days and improvements on the chest roentgenogram in 4.3 days. Eight (53 percent) of the 15 survived and were clinically cured. Five other patients with documented P. carinii infection improved clinically but subsequently died of other causes. Postmortem examination in these showed no P. carinii cysts. Two patients with P. carinii pneumonia died soon after therapy was started and had P. carinii cysts in lung tissue at autopsy. The combined clinical and microbiologic response of 87 percent equals or exceeds that of other reported treatment regimens. Intravenous trimethoprim-sulfamethoxazole may, therefore, be the most ideal therapy for severely ill adults with P. carinii pneumonia. Second lung biopsies in 12 patients on therapy showed that P. carinii cysts were r...Continue Reading

References

Jan 1, 1978·The American Journal of the Medical Sciences·D H Lawson, H Jick
Apr 1, 1978·Antimicrobial Agents and Chemotherapy·J E Bennett, A E Jennings
Dec 29, 1977·The New England Journal of Medicine·W T HughesS L George
Jun 1, 1975·The American Journal of Medicine·P P RosenD Armstrong
Sep 23, 1976·The New England Journal of Medicine·W K Lau, L S Young
Sep 23, 1976·The New England Journal of Medicine·W T Hughes
Jan 1, 1973·Medicine·B A Burke, R A Good
Nov 1, 1973·The Journal of Infectious Diseases·S R Bushby

❮ Previous
Next ❯

Citations

Nov 1, 1987·Parasitology Today·W T Hughes
Dec 1, 1991·Mayo Clinic Proceedings·F R Cockerill, R S Edson
Feb 12, 1983·British Medical Journal·S B Kaye
Jun 1, 1985·Der Internist·A SzabadosF Deinhardt
Mar 1, 1984·The American Journal of Medicine·H W Haverkos
Mar 1, 1983·La Revue de médecine interne·C MayaudJ Roland
Jul 15, 1986·Cancer·J Skelton, P A Pizzo
Jan 1, 1997·Journal of Veterinary Internal Medicine·D C TwedtD M Getzy
Sep 1, 1986·American Journal of Hematology·B H BjornsonA I Tauber
Jan 1, 1984·Annals of the New York Academy of Sciences·A S TeirsteinW Talavera
Aug 1, 1985·Thorax·J T Macfarlane, R G Finch
Apr 17, 2018·Bioconjugate Chemistry·Xiaojian WangNiren Murthy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.